During the past decade, Polyclinique Le Languedoc conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Polyclinique Le Languedoc" #1 collaborator was "Groupe Francais De Pneumo-Cancerologie" with 1 trials as a collaborator and "University Hospital, Caen" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Polyclinique Le Languedoc" are "ALK Gene Mutation" (1 trials), "Adenocarcinoma of Rectum" (1 trials), "BRAF Gene Mutation" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "KRAS Gene Mutation" (1 trials). Many other conditions were trialed in "Polyclinique Le Languedoc" in a lesser frequency.

Most popular intervention types in "Polyclinique Le Languedoc" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "FOLFORINOX" (1 trials), "N-Plate / romiplostim" (1 trials), "Standard Chemotherapy (Pemetrexed and Cisplatin)" (1 trials), "Standard Chemotherapy (Pemetrexed and Cisplatin) + Bevacizumab" (1 trials) and "Systematic use of a prognostic score" (1 trials). Other intervention names were less common.

The vast majority of trials in "Polyclinique Le Languedoc" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Polyclinique Le Languedoc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Polyclinique Le Languedoc, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Polyclinique Le Languedoc, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".